Zhejiang Medicine Co Ltd (600216) – Strategy, SWOT and Corporate Finance Report

Zhejiang Medicine Co Ltd (600216) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Zhejiang Medicine Co Ltd (Zhejiang Medicine) develops, manufactures, and commercializes biological drugs, pharmaceutical intermediates, and bio-pesticides. The company's product portfolio consists of animal nutrition, active pharmaceutical ingredients (APls) and intermediates; antibiotics and human nutrition products including vitamin E, natural vitamin E, vitamin A, vitamin D3 and other pharmaceutical preparations. The company provides its products in large and small volume injections, freeze dried powder injections, tablets, hard and soft capsules, pills and oral solutions. It has two research and development centers, namely, Shaoxing Research Institute of Pharmaceutical Industry and Shanghai Health Creation Biological Drug Research and Development Center. Zhejiang Medicine is headquartered in Shaoxing, Zhejiang, China.

Scope

• Detailed information on Zhejiang Medicine Co Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Zhejiang Medicine Co Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Zhejiang Medicine Co Ltd including a breakdown and examination of key business segments

• News about Zhejiang Medicine Co Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Zhejiang Medicine Co Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Zhejiang Medicine Co Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Zhejiang Medicine Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Hubei Guangji Pharmaceutical Co Ltd

Tasly Pharmaceutical Group Co Ltd

Shandong Xinhua Pharmaceutical Co Ltd

Skystar Bio-Pharmaceutical Co

North China Pharmaceutical Co Ltd

China Resources Jiangzhong Pharmaceutical Group Co Ltd

Zhejiang NHU Co Ltd

Yifan Pharmaceutical Co Ltd

Sinopharm Group Co Ltd

China Meheco Group Co Ltd

Tasly Pharmaceutical Group Co Ltd

China Resources Jiangzhong Pharmaceutical Group Co Ltd

Shandong Xinhua Pharmaceutical Co Ltd

China Meheco Group Co Ltd

Hubei Guangji Pharmaceutical Co Ltd

Skystar Bio-Pharmaceutical Co

North China Pharmaceutical Co Ltd

Yifan Pharmaceutical Co Ltd

Sinopharm Group Co Ltd

Zhejiang NHU Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Zhejiang Medicine Co Ltd - Key Facts

Zhejiang Medicine Co Ltd - Key Employees

Zhejiang Medicine Co Ltd - Key Employee Biographies

Zhejiang Medicine Co Ltd - Major Products and Services

Zhejiang Medicine Co Ltd - History

Zhejiang Medicine Co Ltd - Company Statement

Zhejiang Medicine Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Zhejiang Medicine Co Ltd - Business Description

Product Category: Levofloxacin Series

Performance

Product Category: Miglitol Series

Performance

Product Category: Nerofloxacin Malate Series

Performance

Product Category: Other

Performance

Product Category: Other Business

Performance

Product Category: Progesterone Series

Performance

Product Category: Social Product Distribution

Performance

Product Category: Teicoplanin Series

Performance

Product Category: Vanomycin Hydrochloride Series

Performance

Product Category: Vitamin series

Performance

Geographical Segment: Domestic Sales

Performance

Geographical Segment: Other Business

Performance

Geographical Segment: Overseas Sales

Performance

R&D Overview

Zhejiang Medicine Co Ltd - Corporate Strategy

Zhejiang Medicine Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Zhejiang Medicine Co Ltd - Strengths

Zhejiang Medicine Co Ltd - Weaknesses

Zhejiang Medicine Co Ltd - Opportunities

Zhejiang Medicine Co Ltd - Threats

Zhejiang Medicine Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Zhejiang Medicine Co Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jun 28, 2022: The company's subordinate party branch brand creation phased results inspection ended successfully

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Zhejiang Medicine Co Ltd, Key Facts

Zhejiang Medicine Co Ltd, Key Employees

Zhejiang Medicine Co Ltd, Key Employee Biographies

Zhejiang Medicine Co Ltd, Major Products and Services

Zhejiang Medicine Co Ltd, History

Zhejiang Medicine Co Ltd, Subsidiaries

Zhejiang Medicine Co Ltd, Key Competitors

Zhejiang Medicine Co Ltd, Ratios based on current share price

Zhejiang Medicine Co Ltd, Annual Ratios

Zhejiang Medicine Co Ltd, Annual Ratios (Cont…1)

Zhejiang Medicine Co Ltd, Annual Ratios (Cont…2)

Zhejiang Medicine Co Ltd, Interim Ratios

Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Zhejiang Medicine Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Zhejiang Medicine Co Ltd, Performance Chart (2018 – 2022)

Zhejiang Medicine Co Ltd, Ratio Charts

Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports